<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T12:23:56Z</responseDate>
  <request identifier="oai:figshare.com:article/34034761" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34034761</identifier>
        <datestamp>2026-09-30T17:27:41Z</datestamp>
        <setSpec>category_8</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_62</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Individual Patient-Level Clinical Data of 24 Cases of Refractory Mooren’s Ulcer Treated with Severity-Based Surgical Algorithm.&lt;/p&gt;</dc:title>
          <dc:creator>Minghai Huang (9525231)</dc:creator>
          <dc:creator>Zhifeng Wu (303016)</dc:creator>
          <dc:creator>Dongmei Wei (3836542)</dc:creator>
          <dc:creator>Jixiao Nong (25145089)</dc:creator>
          <dc:creator>Zhuoyuan Zhang (6628634)</dc:creator>
          <dc:creator>Thuthuy Hoang (25145092)</dc:creator>
          <dc:creator>Guina Yin (25145095)</dc:creator>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Marine Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>underwent surgical intervention</dc:subject>
          <dc:subject>mooren &amp;# 8217</dc:subject>
          <dc:subject>meier analysis showed</dc:subject>
          <dc:subject>final anatomical success</dc:subject>
          <dc:subject>failing medical therapy</dc:subject>
          <dc:subject>based surgical strategy</dc:subject>
          <dc:subject>based surgical algorithm</dc:subject>
          <dc:subject>amniotic membrane transplantation</dc:subject>
          <dc:subject>although bcva improved</dc:subject>
          <dc:subject>aggressive disease biology</dc:subject>
          <dc:subject>ulcers &amp;# 8805</dc:subject>
          <dc:subject>primary healing rates</dc:subject>
          <dc:subject>higher recurrence risks</dc:subject>
          <dc:subject>corrected visual acuity</dc:subject>
          <dc:subject>bcva ), recurrence</dc:subject>
          <dc:subject>perforations &amp;# 8804</dc:subject>
          <dc:subject>3 stromal thickness</dc:subject>
          <dc:subject>amt group compared</dc:subject>
          <dc:subject>recurrence rates</dc:subject>
          <dc:subject>ulcers involving</dc:subject>
          <dc:subject>median recurrence</dc:subject>
          <dc:subject>functional acuity</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>term follow</dc:subject>
          <dc:subject>technical infeasibility</dc:subject>
          <dc:subject>sustained immunomodulation</dc:subject>
          <dc:subject>severe cases</dc:subject>
          <dc:subject>retrospective series</dc:subject>
          <dc:subject>penetrating keratoplasty</dc:subject>
          <dc:subject>overall 95</dc:subject>
          <dc:subject>nlp ).</dc:subject>
          <dc:subject>mean follow</dc:subject>
          <dc:subject>local immunosuppression</dc:subject>
          <dc:subject>lamellar keratoplasty</dc:subject>
          <dc:subject>january 2024</dc:subject>
          <dc:subject>free survival</dc:subject>
          <dc:subject>february 2016</dc:subject>
          <dc:subject>clinical outcomes</dc:subject>
          <dc:subject>84 ).</dc:subject>
          <dc:subject>8 %).</dc:subject>
          <dc:subject>36 months</dc:subject>
          <dc:subject>30 months</dc:subject>
          <dc:subject>24 eyes</dc:subject>
          <dc:description>&lt;p&gt;AMT, amniotic membrane transplantation; LK, lamellar keratoplasty; PK, penetrating keratoplasty; BCVA, best-corrected visual acuity (decimal); HM, hand motion; NLP, no light perception; FC, finger counting; CT, corneal thickness; Perf., perforation; OD, right eye; OS, left eye; B/L, bilateral; U/L, unilateral. Note: Of the 24 patients, 8 had bilateral disease. To ensure data independence and avoid inter-eye correlation bias, only the surgically reconstructed eye (AMT, LK, or PK) was analyzed for each patient; contralateral eyes were successfully controlled with conservative management alone. Symptom duration refers to the interval from the onset of ocular symptoms (as reported by the patient) to the date of surgical intervention at our institution. BCVA is presented in decimal notation. For statistical analysis, HM and FC were assigned logMAR values of 2.30 and 2.00, respectively. Em dash (—) in the “Time to First Recurrence” column indicates that no recurrence event occurred during follow-up. “NA” (not applicable) for Case 2 indicates that the eye was excluded from recurrence analysis due to failed initial healing after lamellar keratoplasty.&lt;/p&gt; &lt;p&gt;(XLSX)&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T17:27:38Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0359413.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Individual_Patient-Level_Clinical_Data_of_24_Cases_of_Refractory_Mooren_s_Ulcer_Treated_with_Severity-Based_Surgical_Algorithm_p_/34034761</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
